China Biologic Rejects $3.9B Takeover Bid Led By Ex-CEO
China Biologic Products Holdings Inc. on Friday rejected a $3.9 billion offer from a consortium that includes its former chief executive and several investment firms, while the biopharmaceutical company also said...To view the full article, register now.
Already a subscriber? Click here to view full article